OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
65
Results
Show all
Save search
Copy query
Show results for
Unknown
(65)
Publication Date
Release Date
2022
(14)
2020
(8)
2025
(7)
2023
(6)
2024
(5)
2018
(5)
2021
(4)
2016
(4)
2014
(3)
2013
(3)
2012
(2)
2026
(1)
2017
(1)
2009
(1)
2008
(1)
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
α-Synuclein oligomers in skin biopsy of idiopathic and monozygotic twin patients with Parkinson's disease.
Not available
S-EPMC7089656
|
biostudies-literature
Cite
Validity of Bioimpedance Equations to Evaluate Fat-Free Mass and Muscle Mass in Severely Malnourished Anorectic Patients.
Not available
S-EPMC7698304
|
biostudies-literature
Cite
Marine viruses disperse bidirectionally along the natural water cycle.
Not available
S-EPMC10564846
|
biostudies-literature
Cite
The Clinical Spectrum of ANO3-Report of a New Family and Literature Review.
Not available
S-EPMC10928356
|
biostudies-literature
Cite
Lifestyle, Cognitive, and Psychological Factors Associated With a Resilience Phenotype in Aging: A Multidimensional Approach on a Population-Based Sample of Oldest-Old (80+).
Not available
S-EPMC11402365
|
biostudies-literature
Cite
Finding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsy.
Not available
S-EPMC4862050
|
biostudies-literature
Cite
Optimizing the Safety Profile of Everolimus by Delayed Initiation in De Novo Heart Transplant Recipients: Results of the Prospective Randomized Study EVERHEART.
Not available
S-EPMC5828375
|
biostudies-literature
Cite
Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy.
Not available
S-EPMC5908108
|
biostudies-literature
Cite
Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa.
Not available
S-EPMC7566883
|
biostudies-literature
Cite
Safety and Effectiveness of Cell Therapy in Neurodegenerative Diseases: Take-Home Messages From a Pilot Feasibility Phase I Study of Progressive Supranuclear Palsy.
Not available
S-EPMC8546103
|
biostudies-literature
Cite
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets